When a cell needs to produce a protein, it first makes an mRNA copy of the relevant gene. This mRNA copy then travels to the cytoplasm and attaches to a ribosome, where it can be read and translated into a protein chain.
mRNA is essential for all living cells, and it is also a key component in some COVID-19 vaccines. These vaccines work by introducing synthetic mRNA into human cells, which then produce a protein that resembles the outer spike of the coronavirus.
This prompts the immune system to create antibodies that can recognize and attack the coronavirus, providing protection against future infection.
As a way of vaccination,mRNA vaccines offer several potential advantages over traditional vaccines. They can be produced more quickly, they are less likely to cause side effects, and they are potentially more effective at preventing infection. However, mRNA vaccines are also relatively new, and there is still some uncertainty about their long-term safety and efficacy.
